(+)-Quinidine

(+)-Quinidine, with a CAS number of 56-54-2, is a pharmaceutical compound that exhibits Class I anti-arrhythmic properties, primarily used to treat various cardiac arrhythmias. It functions by blocking sodium channels, thereby reducing the rate of increase in cardiac action potential and prolonging the effective refractory period. As a result, (+)-Quinidine can effectively manage conditions such as atrial fibrillation and ventricular tachycardia. The compound is often administered orally, with its pharmacokinetics characterized by extensive hepatic metabolism and a relatively long half-life. However, its use can be associated with several side effects, including gastrointestinal disturbances, cinchonism, and potentially severe pro-arrhythmic effects, necessitating careful patient monitoring and dose adjustment to minimize adverse reactions and optimize therapeutic outcomes. Its narrow therapeutic index requires precise dosing to achieve efficacy while minimizing toxicity.